Ajanta Pharma Ltd. Conference Calls and Earnings Call Transcripts

Ajanta Pharma Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Ajanta Pharma Ltd.
11 May 2023
2544.60
-0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Further to our communication dated 5th May 2023 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 5th May 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link https://ajantapharma.com//images/EarningsCallTranscriptQ4(Jan-Mar)2022-23.pdf.
pdf
logo
Ajanta Pharma Ltd.
05 May 2023
2544.60
-0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 5th May 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EAC-Q4-(Jan-Mar)-2022-23.mp3 Written transcript of the same will be submitted in due course. This is for your information and records please.
pdf
logo
Ajanta Pharma Ltd.
05 May 2023
2544.60
-0.15%
Ajanta Pharma Results Earnings Call for Q4FY23
Conference Call with Ajanta Pharma Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
logo
Ajanta Pharma Ltd.
13 Feb 2023
2544.60
-0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Further to our communication dated 2nd February 2023 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 1st February 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EarningsCallTranscriptQ3(Oct-Dec)2022-23.pdf
pdf
logo
Ajanta Pharma Ltd.
02 Feb 2023
2544.60
-0.15%
pdf
logo
Ajanta Pharma Ltd.
01 Feb 2023
2544.60
-0.15%
Ajanta Pharma Results Earnings Call for Q3FY23
Conference Call with Ajanta Pharma Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
logo
Ajanta Pharma Ltd.
10 Nov 2022
2544.60
-0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Further to our communication dated 3rd November 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 3rd November 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link https://ajantapharma.com//images/EarningsCallTranscriptQ2FY23.pdf .
pdf
logo
Ajanta Pharma Ltd.
04 Nov 2022
2544.60
-0.15%
pdf
logo
Ajanta Pharma Ltd.
03 Nov 2022
2544.60
-0.15%
Results Earnings Call for Q2FY23 of Ajanta Pharma
Conference Call with Ajanta Pharma Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
logo
Ajanta Pharma Ltd.
03 Aug 2022
2544.60
-0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Further to our communication dated 29th July 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed written transcript of the earnings call held on 28th July 2022 at 5.00 p.m. Further, written transcript has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ1(Apr-Jun)2022-23.pdf This is for your information and records please.
pdf

Earnings Calls Podcast on